# Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA

> **NCT05354765** · NA · RECRUITING · sponsor: **Institut Curie** · enrollment: 300 (estimated)

## Conditions studied

- Cancer
- Immune System or Toxicities Suspected

## Interventions

- **OTHER:** blood sample
- **OTHER:** blood sample

## Key facts

- **NCT ID:** NCT05354765
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-31
- **Primary completion:** 2027-09-03
- **Final completion:** 2027-09-03
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354765, "Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05354765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*